Form 10-K Kite Pharma, Inc. For: Dec 31
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/2/2026
- Wall St mixed as investors assess softer jobs data
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Oil falls to four-month low as US, Iran conclude talks in Doha
- Rivian stock jumps 5% on raised delivery outlook
- Analysis-Excommunications show a Pope Leo unafraid of making firm decisions
- Whirlpool to close Mexico plant, expects $165M restructuring cost
- Meta Platforms stock surges 8% on cloud business plans
- Canaccord Starts Infleqtion, Inc (INFQ) at Buy
- Wall Street ends choppy session lower as tech shares drop
Kite Pharma (KITE) Posts Q4 Loss of 85c/Share
February 29, 2016 3:38 PM ESTKite Pharma (NASDAQ: KITE) reported Q4 EPS of ($0.85), which may not compare with the analyst estimate of ($0.71). Revenue for the quarter came in at $4.89 million versus the consensus estimate of $4.54 million.
For earnings history and earnings-related data on Kite Pharma (KITE) click here.
... More